Literature DB >> 18014217

Use of Convalescent Measles Serum to Control Measles in a Preparatory School.

J R Gallagher.   

Abstract

Year:  1935        PMID： 18014217      PMCID： PMC1559172          DOI： 10.2105/ajph.25.5.595

Source DB:  PubMed          Journal:  Am J Public Health Nations Health        ISSN： 0002-9572


× No keyword cloud information.
  12 in total

1.  Antibody prophylaxis and therapy against Nipah virus infection in hamsters.

Authors:  V Guillaume; H Contamin; P Loth; I Grosjean; M C Georges Courbot; V Deubel; R Buckland; T F Wild
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  The convalescent sera option for containing COVID-19.

Authors:  Arturo Casadevall; Liise-Anne Pirofski
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

Review 3.  Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19.

Authors:  Ramtin Pourahmad; Bobak Moazzami; Nima Rezaei
Journal:  SN Compr Clin Med       Date:  2020-07-31

Review 4.  Botulinum neurotoxins and botulism: a novel therapeutic approach.

Authors:  Jeeraphong Thanongsaksrikul; Wanpen Chaicumpa
Journal:  Toxins (Basel)       Date:  2011-05-13       Impact factor: 4.546

5.  Innate immune-mediated antiviral response to SARS-CoV-2 and convalescent sera a potential prophylactic and therapeutic agent to tackle COVID-19.

Authors:  Shah Faisal; Komal Aman; Anees Ur Rahman
Journal:  Antib Ther       Date:  2020-08-16

Review 6.  Potential strategies for combating COVID-19.

Authors:  Saba Shamim; Maryam Khan; Zelal Jaber Kharaba; Munazza Ijaz; Ghulam Murtaza
Journal:  Arch Virol       Date:  2020-08-10       Impact factor: 2.574

Review 7.  Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic.

Authors:  H Cliff Sullivan; John D Roback
Journal:  Transfus Med Rev       Date:  2020-04-23

Review 8.  Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment.

Authors:  Norma A Valdez-Cruz; Enrique García-Hernández; Clara Espitia; Laura Cobos-Marín; Claudia Altamirano; Carlos G Bando-Campos; Luis F Cofas-Vargas; Enrique W Coronado-Aceves; Ricardo A González-Hernández; Pablo Hernández-Peralta; Daniel Juárez-López; Paola A Ortega-Portilla; Sara Restrepo-Pineda; Patricio Zelada-Cordero; Mauricio A Trujillo-Roldán
Journal:  Microb Cell Fact       Date:  2021-04-22       Impact factor: 5.328

Review 9.  Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2.

Authors:  Nikola Hudakova; Simona Hricikova; Amod Kulkarni; Mangesh Bhide; Eva Kontsekova; Dasa Cizkova
Journal:  Pathogens       Date:  2021-05-21

10.  Clinical use of Convalescent Plasma in the COVID-19 pandemic: a transfusion-focussed gap analysis with recommendations for future research priorities.

Authors:  Arwa Z Al-Riyami; Richard Schäfer; Karin van den Berg; Evan M Bloch; Lise J Estcourt; Ruchika Goel; Salwa Hindawi; Cassandra D Josephson; Kevin Land; Zoe K McQuilten; Steven L Spitalnik; Erica M Wood; Dana V Devine; Cynthia So-Osman
Journal:  Vox Sang       Date:  2020-09-03       Impact factor: 2.144
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.